Vaccines List

Leronlimab (PRO 140)

Leronlimab (PRO 140) is a drug candidate that is a CCR5 antagonist with the potential for multiple therapeutic indications.Read more...

LY-CoV555 COVID-19 Treatment

LY-CoV555 is a neutralizing IgG1 monoclonal antibody directed against the spike protein of SARS-CoV-2. In addition to LY-CoV555 a second Lilly antibody, LY-CoV016, which binds a different epitope in the SARS-CoV-2 spike region has been added to the BLAZE-1 clinical trial.Read more...